Botswana Diamonds secures licenses for AI exploration
Botswana Diamond has secured four research licences in Botswana and marked a significant milestone achieved through its innovative AI-driven exploration programme.
The licence covering an area of 2,644 km² is granted for diamond exploration in strategically identified regions with high potential.
The awarded licenses (PL298, PL303, PL304, and PL305) are valid until 2025 and are spread across diverse locations, including the northwest of Mahalapie, near the South African border in northeastern Lerallal in eastern Botswana, near the KX36 in Kalahari.
The license near the Jwaneng mine is particularly noteworthy due to its promising anomaly signature, suggesting the existence of multiple potential kimberlite sources.
The AI model employed in Botswana Diamond incorporates a variety of factors that indicate the presence of diamonds, such as mineral chemistry, major geological structures, and specific geophysical anomalies.
This methodology also considered the presence of distinctive low magnetic features of slightly worn stones, shallow calakali covers, and group 2 kimberlites.
Beyond diamond-centric licenses, the AI exploration model has also identified non-diamond targets, leading to 11 polymetallic licensed applications for minerals such as cobalt, copper, gold, nickel, platinum group metals, silver and zinc.
Some of these applications cover areas previously described for copper-related signals.
The company has received tentative acceptance for these applications and expects more positive developments in terms of official grants.
“Botswana Diamonds will be licensed with AI Exploration” was originally created and published Mining Technologya brand owned by GlobalData.
The information on this site is contained in good faith for general information purposes only. It is not intended to be the advice you should resort to, and we will not give any representations, warranties or warranties, whether express or implied regarding its accuracy or completeness. You should seek expert or expert advice before taking or refraining from taking any medication based on the content on our site.